Clinical gait analysis 1973-2023: Evaluating progress to guide the future.

Clinical gait analysis has been used to inform treatment for over 50 years. Over that period there have been significant advances in motion capture technology and software development, driven in part by innovations in biomechanics. The aim of this paper is to review the current state of the art in gait analysis, mapping progress over the last five decades using the collective experience of the community of researchers and clinicians.An online survey was circulated to gait analysts to canvas opinion and responses were received from 229 people from 28 countries.Respondents identified the greatest progress in the areas of hardware, automation of processes, and software development. Despite laboratories being better equipped, many of today's challenges would have been very familiar to those working in 1973. Better algorithms and more evidence are needed to establish a secure link between gait analysis data and clinical decision making. Biomechanical models require further refinement to overcome well known limitations. Despite innovation, clinical gait analysis remains relatively unknown in the wider healthcare field.Growth in the global Gait Analysis communities and advances in remote communication technology have created new opportunities for taking on this challenge over the next 50 years. Hopefully, future innovation will lead to clinical gait analysis becoming more accessible, more flexible to real world mobility and more able to exploit emerging advanced modelling techniques.

Editorial: The society for environmental geochemistry and health (SEGH): 50 years and beyond.

When the SEGH international board released a short editorial paper back in 2019, we described an aim to increase the membership offering, whilst improving the diversity of input regionally, by scientific discipline and to ensure greater and more regular contact across the regions from 2020 onwards. Wider aspirations described in 2019 (Watts et al. 2019) are discussed within this short communication at the end of 2021 to evaluate progress made. In particular, how the SEGH community adapted to the unprecedented circumstances that have challenged each and every one of us throughout the COVID-19 pandemic since early 2020 and are likely to influence our activities for the foreseeable future.

[50 years of the Neonatal Screening Program in Catalonia.] / 50 años del Programa de Cribado Neonatal en Cataluña.

The Catalonian Newborn Screening Program (CNSP) began in 1969, in Barcelona. It was promoted by Dr. Juan Sabater Tobella and supported by Barcelona Provincial Council and Juan March Foundation. That is how the Institute of Clinical Biochemistry was born, whose aims were diagnosis, research and teaching, along with the spirit of contributing to the prevention of mental retardation. The CNSP began with the detection of phenylketonuria (PKU), and, in 1982, the Program was expanded with the inclusion of congenital hypothyroidism detection. Towards 1990, the Program covered almost 100% of all newborns (NB) in Catalonia. In 1999, the CNSP was expanded with the incorporation of cystic fibrosis. It took fourteen years, until 2013, to make the largest expansion so far, with the incorporation of 19 metabolic diseases to the screening panel. The detection of sickle cell disease began in 2015 and in 2017 the detection of severe combined immunodeficiency was included. Currently, the CNSP includes 24 diseases in its main panel. Since 1969, 2,787,807 NBs have been screened, of whom 1,724 have been diagnosed with any of these diseases, and 252 of other disorders by differential diagnosis with those included in the main panel. The global prevalence is 1: 1,617 NBs affected by any of the diseases included in the CNSP and 1: 1,140 NBs if incidental findings diagnosed through the CNSP are included.

El Programa de Cribado Neonatal de Cataluña (PCNC) se inició en el año 1969, en Barcelona, impulsado por el Dr. Juan Sabater Tobella y apoyado por la Diputación de Barcelona y la Fundación Juan March. Así nació el Instituto de Bioquímica Clínica para acometer funciones asistenciales, de investigación y docencia, con el espíritu de contribuir a la prevención del retraso mental. El PCNC se inició con la detección de la fenilcetonuria (PKU) y en el año 1982 se amplió con la detección del hipotiroidismo congénito. Hacia el año 1990 la cobertura territorial llegó casi al 100% de todos los recién nacidos en Cataluña. En 1999 se amplió el PCNC con la incorporación de la fibrosis quística y tras catorce años, en 2013, se realizó la ampliación más numerosa hasta ahora, con la incorporación de la detección de 19 enfermedades metabólicas hereditarias. En el año 2015 comenzó la detección de la enfermedad de células falciformes y en el 2017 la detección de la inmunodeficiencia combinada grave. Actualmente, el PCNC incluye la detección de 24 enfermedades. Desde su inicio en el año 1969, se han cribado 2.787.807 recién nacidos, de los cuales 1.724 han sido diagnosticados de alguna de las 24 enfermedades que componen nuestro panel principal y 252 por diagnóstico diferencial de las primeras. En total la prevalencia global es de 1:1.617 RN afectos de alguna de las enfermedades incluidas en el PCNC y de 1:1.140 RN si se incluyen los hallazgos incidentales encontrados.

APSA 5.0: Saving even more lifetimes the Jay and Margie Grosfeld presidential symposium.

In light of APSA's 50th Anniversary, the typical Presidential Address was transformed into a "symposium" consisting of talks on the maturation of our organization to APSA 5.0 and the issues and opportunities related to its internal and external environment, especially as they apply to our pediatric surgical patients. Speakers included the President and experts in the fields of diversity, as well as inequity and poverty in the United States.

Power of the Past, Celebrate the Present, Force of the Future-Part 6: NASN-The Next 50 Years.

NASN is celebrating 50 years of supporting the health needs of children and the practice needs of the school nurses who provide those services. This is the sixth and last in a series exploring the power of NASN's past, its celebration of the present and preparing for NASN to be a force of the future. This article builds on the historical precedents of NASN's history to develop a vision for its next 50 years. Examining the changing landscape of healthcare provides the outline of NASN's potential to advance child health.

Power of the Past, Celebrate the Present, Force of the Future-Part 5: A Look Into Our Next 50 Years . . .

The July 2018 issue of the NASN School Nurse, featured the first in a series of articles exploring the history, examining the present, and visioning the future of our organization in celebration of NASN's 50th anniversary. While Parts 1 through 4 of this series focuses on the past and present, Part 5 is the first of two articles presenting the force of the future. In developing the content for Part 5, the authors posed a question to past and current NASN Officers, State Directors, and other school nursing colleagues. Areas of identified importance are grouped into the following major headings: research, education, collaboration, advocacy, image, technology, and leadership.

CAPS at 50: Now comfortably seated with the grownups.

The Canadian Association of Pediatric Surgeons was established 50 years ago, with 30 founding members. Since then, the CAPS membership has grown nearly 10-fold and has developed a global presence with representation from 15 countries. CAPS has 8 pediatric surgery training programs which contribute not only to the North American workforce, but also to profoundly underserved low and middle income countries, particularly in Africa. On the occasion of our 50th Anniversary meeting, we celebrate our diversity and inclusivity as we reflect on our past, on the contributions of our Founding Members, the Women of CAPS, and others who have had a transformational impact on the practice of pediatric surgery. We look forward to our future, which while unknown, holds great promise for future generations of pediatric surgeons and the children and families in need of their care.

The Canadian Liver Foundation celebrates 50 years of commitment to hepatology.

Founded in 1969, the Canadian Liver Foundation (CLF) was the first foundation worldwide to support research and education relating specifically to the liver and liver diseases. This year marks its 50th anniversary. It has been highly effective in promoting hepatology in Canada.

[On the 50th anniversary of Anales de Pediatría, official publication of the Spanish Association of Paediatrics]. / En los 50 años de Anales de Pediatría, publicación oficial de la Asociación Española de Pediatría.

The 50th Anniversary of Anales de Pediatría is a good time for the celebration of events and tributes, and also for critical thought. Anales de Pediatría is the official publication of scientific expression of the Spanish Association of Paediatrics (AEP). It has been published continuously since October 1968. Anales has contributed so much to the narrative of the advances in Spanish paediatrics, as well as the AEP. Throughout its 50 years of history, the editorial teams of the journal have worked to streamline its management, improve the quality of the content, and to ensure its dissemination and national-international visibility. From 1968 to 1972, Anales was published as a Journal-bulletin. From 1977 until 2000, presence of original articles. Since the year 2000, continuous modernisation and recognition with international journals of prestige, indexing in SCI-JCR, impact from 2009, electronic management of manuscripts, Spanish/English from the 2014 Edition. The evolution of the journal is reviewed in this article. With this, the AEP history committee wants to collaborate in a greater understanding of the development of Spanish paediatrics, as well as to present the history of Anales to its authors and readers. The History committee proposes that a small percentage of space is destined for the humanities and to the humanisation of paediatrics. Best information will ensure the best care for children and also for paediatricians.

Power of the Past, Celebrate the Present, Force of the Future Part 2: Our Story-NASN's Second 25 Years.

The July 2018 issue of the NASN School Nurse, featured the first in a series of articles exploring the history, examining the present, and visioning the future of our organization in celebration of NASN's 50th anniversary. Part 2 of our historical account reflects on the leadership of a new generation of clinicians, reviewing the major emphases and accomplishments of NASN presidents serving from 1993 to today.

50 years of Dutch immunology--founders, institutions, highlights.

At the occasion of the 50th anniversary of the Dutch Society for Immunology (DSI, de Nederlandse Vereniging voor Immunologie), this contribution deals with some highlights of 50 years of Immunology in the Netherlands. It narrates about the founders and first board members of the DSI, their institutes, progeny and patrimony, describes major centers of immunological activities, mentions key persons in the field, and touches upon some events dear to the Society and its members.

World Association for the Advancement of Veterinary Parasitology (WAAVP): the 50th anniversary in 2013--history, achievements, and future perspectives.

In 2013 the World Association for the Advancement of Veterinary Parasitology (WAAVP) can celebrate its 50th anniversary. At this occasion in this article selected historical data are updated, and the achievements and future perspectives of the WAAVP are discussed. Although the WAAVP is a small association with only a few hundred members, it has been able to develop remarkable activities. Between 1963 and 2011 the WAAVP has organized 23 international scientific congresses, and the 24th conference will take place in Perth, Western Australia, in 2013. These conferences have achieved a high degree of international recognition as indicated by relatively large numbers of participants (up to ~800). Furthermore, the WAAVP has promoted veterinary parasitology in various ways, such as publishing international guidelines (efficacy evaluation of antiparasitic drugs, parasitological methods, standardized nomenclature of animal parasitic diseases "SNOAPAD"), stimulating international discussions on teaching and continued education ("colleges of veterinary parasitology") and by supporting the high quality journal "Veterinary Parasitology" which is the official organ of the WAAVP. In retrospect, the development of the WAAVP can be classified as very successful. New challenges associated with global changes (growth of the world population, urbanization, climate change, new developments in animal and plant production, etc.) will require new efforts in research in various fields, including veterinary parasitology. Future activities of WAAVP may include inter alia: (a) support of international parasitological networks; (b) stimulation of coordinated research aimed at the solution of defined problems; (c) increasing the exposure of WAAVP to parasitology from hitherto neglected regions of the world; (d) strengthening of official links to international organizations (FAO, WHO, etc.); (e) continuation of guideline preparation; and (d) preparation and international distribution of high quality electronic programs for self-education in veterinary parasitology.